A phase 3 study evaluated the safety and efficacy of oral paclitaxel versus intravenous paclitaxel monotherapy in patients with metastatic breast cancer.
— Read on www.specialtypharmacytimes.com/
Oral therapies are still effective…..
A phase 3 study evaluated the safety and efficacy of oral paclitaxel versus intravenous paclitaxel monotherapy in patients with metastatic breast cancer.
— Read on www.specialtypharmacytimes.com/
Oral therapies are still effective…..